Company Filing History:
Years Active: 2019-2023
Title: Englong Tan: Innovative Medical Device Inventor
Introduction:
Introducing Englong Tan, an ingenious inventor and a dedicated member of the medical device development community. With a strong background in engineering and several patents to his name, Tan has made significant contributions to the field of medical technology. In this article, we will delve into his latest invention, explore his notable patents, and shed light on his professional endeavors.
Englong Tan's Inventions:
One of Tan's notable contributions is the development of an innovative medical device known as the Uncoupled Left Atrial Appendage (LAA) device. Specifically designed to treat LAA, this device comprises a cap, a bulb, and a joint assembly.
The cap, constructed as a three-layer mesh structure, is secured together by a retaining hub. The device incorporates a multitude of proximal wire loops extending from the base layer to a proximal post. Similarly, the bulb consists of distal wire loops extending between a terminal post and a distal post of the joint assembly.
The joint assembly, made up of a first and second ball joint as well as a housing, allows for independent ball and socket relationships. By employing this unique mechanism, the device offers flexibility in adjusting the angles formed by the longitudinal axes of the ball joints and the housing in various directions, ranging from 0 to 35 degrees.
Patents:
Englong Tan holds two patents related to his groundbreaking work in medical device development. Both patents are related to his invention, the Uncoupled LAA device. These patents highlight Tan's dedication to innovating and improving medical technology.
Professional Background and Company Affiliation:
Englong Tan is an invaluable member of Cardia, Inc., a renowned medical technology company dedicated to creating innovative solutions for cardiovascular diseases. At Cardia, Tan collaborates with a team of accomplished professionals, including his coworkers Michael Patrick Corcoran and Joseph A Marino. Together, they strive to revolutionize patient care through cutting-edge advancements in medical devices.
Conclusion:
Englong Tan's remarkable contributions to the field of medical device development, particularly in the area of LAA treatment, showcase his commitment to improving patient outcomes. With his dedication to innovation and ongoing collaboration with colleagues at Cardia, Inc., Tan continues to make substantial strides in the advancement of medical technology. Keeping an eye on his future endeavors promises exciting prospects for the medical device industry as a whole.